Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Aug 30;10(8):e036107. doi: 10.1136/bmjopen-2019-036107

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

PMC Copyright notice

The results of univariable sensitivity analysis in China: (A) F&A versus FUL; (B) F&A versus ANA. This diagram shows incremental cost-effectiveness ratio (ICER) of F&A versus FUL 500 mg versus ANA for different model input parameters. For example, F&A compared with ANA, the dotted line intersecting the sky blue and orange bars represents the ICER of US$15 665.89 per quality-adjusted life-year (QALY) in China from the base case results. ANA, anastrozole; F&A, fulvestrant plus anastrozole treatment group; FUL, fulvestrant; PFS, progression-free survival; PD, progressed disease.